Clinical Trial Update: VA NEPHRON-D: Diabetes iN Nephropathy Study [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing dual RAAS blockade with losartan plus lisinopril in diabetic nephropathy was terminated early due to safety concerns, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Lisinopril (Lisinopril)
• Losartan (losartan)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Kidney Disease, Nephropathy | Phase 3 | Status: TERMINATED | Results posted: 2015-05-29